92 related articles for article (PubMed ID: 17390293)
1. Biomarker clustering to address correlations in proteomic data.
Carlson SM; Najmi A; Cohen HJ
Proteomics; 2007 Apr; 7(7):1037-46. PubMed ID: 17390293
[TBL] [Abstract][Full Text] [Related]
2. Proteomic data analysis workflow for discovery of candidate biomarker peaks predictive of clinical outcome for patients with acute myeloid leukemia.
Forshed J; Pernemalm M; Tan CS; Lindberg M; Kanter L; Pawitan Y; Lewensohn R; Stenke L; Lehtiö J
J Proteome Res; 2008 Jun; 7(6):2332-41. PubMed ID: 18452325
[TBL] [Abstract][Full Text] [Related]
3. A novel approach for clustering proteomics data using Bayesian fast Fourier transform.
Bensmail H; Golek J; Moody MM; Semmes JO; Haoudi A
Bioinformatics; 2005 May; 21(10):2210-24. PubMed ID: 15769836
[TBL] [Abstract][Full Text] [Related]
4. Benchmarking currently available SELDI-TOF MS preprocessing techniques.
Emanuele VA; Gurbaxani BM
Proteomics; 2009 Apr; 9(7):1754-62. PubMed ID: 19294696
[TBL] [Abstract][Full Text] [Related]
5. A stable iterative method for refining discriminative gene clusters.
Xu M; Zhu M; Zhang L
BMC Genomics; 2008 Sep; 9 Suppl 2(Suppl 2):S18. PubMed ID: 18831783
[TBL] [Abstract][Full Text] [Related]
6. An extended Markov blanket approach to proteomic biomarker detection from high-resolution mass spectrometry data.
Oh JH; Gurnani P; Schorge J; Rosenblatt KP; Gao JX
IEEE Trans Inf Technol Biomed; 2009 Mar; 13(2):195-206. PubMed ID: 19126475
[TBL] [Abstract][Full Text] [Related]
7. Data analysis of assorted serum peptidome profiles.
Villanueva J; Philip J; DeNoyer L; Tempst P
Nat Protoc; 2007; 2(3):588-602. PubMed ID: 17406620
[TBL] [Abstract][Full Text] [Related]
8. A mixture model approach to the tests of concordance and discordance between two large-scale experiments with two-sample groups.
Lai Y; Adam BL; Podolsky R; She JX
Bioinformatics; 2007 May; 23(10):1243-50. PubMed ID: 17384018
[TBL] [Abstract][Full Text] [Related]
9. Simultaneous and exact interval estimates for the contrast of two groups based on an extremely high dimensional variable: application to mass spec data.
Park Y; Downing SR; Kim D; Hahn WC; Li C; Kantoff PW; Wei LJ
Bioinformatics; 2007 Jun; 23(12):1451-8. PubMed ID: 17459967
[TBL] [Abstract][Full Text] [Related]
10. Proteomic analysis to identify biomarker proteins in pancreatic ductal adenocarcinoma.
Chung JC; Oh MJ; Choi SH; Bae CD
ANZ J Surg; 2008 Apr; 78(4):245-51. PubMed ID: 18366394
[TBL] [Abstract][Full Text] [Related]
11. Serum proteomics and biomarkers in hepatocellular carcinoma and chronic liver disease.
Zinkin NT; Grall F; Bhaskar K; Otu HH; Spentzos D; Kalmowitz B; Wells M; Guerrero M; Asara JM; Libermann TA; Afdhal NH
Clin Cancer Res; 2008 Jan; 14(2):470-7. PubMed ID: 18223221
[TBL] [Abstract][Full Text] [Related]
12. MetaClustering: discovery of the different sample clusterings in gene expression data.
Venet D; Bersini H; Iba H
Genome Inform; 2006; 17(2):172-83. PubMed ID: 17503390
[TBL] [Abstract][Full Text] [Related]
13. Identification of lung cancer patients by serum protein profiling using surface-enhanced laser desorption/ionization time-of-flight mass spectrometry.
Han KQ; Huang G; Gao CF; Wang XL; Ma B; Sun LQ; Wei ZJ
Am J Clin Oncol; 2008 Apr; 31(2):133-9. PubMed ID: 18391596
[TBL] [Abstract][Full Text] [Related]
14. Potential biomarkers of acute cerebral infarction detected by SELDI-TOF-MS.
Zhang X; Guo T; Wang H; He W; Mei H; Hong M; Yu J; Hu Y; Song S
Am J Clin Pathol; 2008 Aug; 130(2):299-304. PubMed ID: 18628101
[TBL] [Abstract][Full Text] [Related]
15. Independent component analysis for the extraction of reliable protein signal profiles from MALDI-TOF mass spectra.
Mantini D; Petrucci F; Del Boccio P; Pieragostino D; Di Nicola M; Lugaresi A; Federici G; Sacchetta P; Di Ilio C; Urbani A
Bioinformatics; 2008 Jan; 24(1):63-70. PubMed ID: 18003646
[TBL] [Abstract][Full Text] [Related]
16. Guilt-by-association feature selection: identifying biomarkers from proteomic profiles.
Shin H; Sheu B; Joseph M; Markey MK
J Biomed Inform; 2008 Feb; 41(1):124-36. PubMed ID: 17544868
[TBL] [Abstract][Full Text] [Related]
17. The application of SELDI-TOF mass spectrometry to mammalian cell culture.
Woolley JF; Al-Rubeai M
Biotechnol Adv; 2009; 27(2):177-84. PubMed ID: 19049820
[TBL] [Abstract][Full Text] [Related]
18. Quantitative quality-assessment techniques to compare fractionation and depletion methods in SELDI-TOF mass spectrometry experiments.
Harezlak J; Wang M; Christiani D; Lin X
Bioinformatics; 2007 Sep; 23(18):2441-8. PubMed ID: 17626063
[TBL] [Abstract][Full Text] [Related]
19. Clinical perspectives of high-resolution mass spectrometry-based proteomics in neuroscience: exemplified in amyotrophic lateral sclerosis biomarker discovery research.
Ekegren T; Hanrieder J; Bergquist J
J Mass Spectrom; 2008 May; 43(5):559-71. PubMed ID: 18416436
[TBL] [Abstract][Full Text] [Related]
20. Discrimination analysis of mass spectrometry proteomics for ovarian cancer detection.
Hong YJ; Wang XD; Shen D; Zeng S
Acta Pharmacol Sin; 2008 Oct; 29(10):1240-6. PubMed ID: 18817630
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
